4//SEC Filing
Vizirgianakis Stavros G. 4
Accession 0001235802-23-000094
CIK 0001453593other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:38 PM ET
Size
7.6 KB
Accession
0001235802-23-000094
Insider Transaction Report
Form 4
Vizirgianakis Stavros G.
Director
Transactions
- Award
Common Stock
2023-08-15+217,770→ 6,213,125 total - Award
Stock Option (right to buy)
2023-08-15+42,345→ 42,345 totalExercise: $1.20Exp: 2033-08-15→ Common Stock (42,345 underlying)
Footnotes (3)
- [F1]These shares are subject to a deferred stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, and vest on August 15, 2024, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date.
- [F2]Includes 217,770 shares issuable upon settlement of deferred stock units granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date.
- [F3]This option vests on August 15, 2024, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date.
Documents
Issuer
Xtant Medical Holdings, Inc.
CIK 0001453593
Entity typeother
Related Parties
1- filerCIK 0001559834
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 4:38 PM ET
- Size
- 7.6 KB